Compulsory licensing of pharmaceuticals during public health crisis: a TRIPS framework analysis
{{output}}
The COVID-19 pandemic has exposed inequities in global healthcare resource allocation, reigniting debates over international intellectual property (IP) protections. Among existing flexibility mechanisms, the TRIPS Agreement's compulsory licensing provisions s... ...
